# FDA Inspection 1233226 - GlaxoSmithKline Vaccines S.r.l. - January 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-vaccines-srl/20da7e26-8b87-4d67-a0de-8508a80668cb
Source feed: FDA_Inspections

> FDA Inspection 1233226 for GlaxoSmithKline Vaccines S.r.l. on January 26, 2024. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1233226
- Company Name: GlaxoSmithKline Vaccines S.r.l.
- Inspection Date: 2024-01-26
- Product Type: Biologics
- Office Name: Office of Inspections and Investigations

## Related Documents

- [FDA Inspection 1030020 - 2017-05-29](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-vaccines-srl/a22d58f4-696a-4e53-88fb-f0c6c3c6ed78)
- [FDA Inspection 683109 - 2010-06-18](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-vaccines-srl/15846114-2c1f-4413-9b81-69d6daf5d89f)

Company: https://www.keypedia.com/companies/glaxosmithkline-vaccines-srl/cddb07b7-c8a6-4dbd-a92c-c6ebeeb7e009

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8